Citadel Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,854,309
| Closed | -$681M | – | 10285 |
|
|
2019
Q3 | $681M | Buy |
6,854,309
+1,815,193
| +36% | +$172M | 0.32% | 33 |
|
|
2019
Q2 | $466M | Buy |
5,039,116
+3,794,539
| +305% | +$360M | 0.21% | 44 |
|
|
2019
Q1 | $117M | Sell |
1,244,577
-785,315
| -39% | -$68.7M | 0.06% | 304 |
|
|
2018
Q4 | $130M | Buy |
2,029,892
+747,067
| +58% | +$55.1M | 0.07% | 239 |
|
|
2018
Q3 | $115M | Buy |
1,282,825
+142,848
| +13% | +$12.6M | 0.05% | 364 |
|
|
2018
Q2 | $90.5M | Buy |
1,139,977
+1,096,126
| +2,500% | +$91M | 0.04% | 411 |
|
|
2018
Q1 | $3.91M | Sell |
43,851
-3,665,065
| -99% | -$352M | ﹤0.01% | 2759 |
|
|
2017
Q4 | $387M | Buy |
+3,708,916
| New | +$418M | 0.24% | 47 |
|
|
2017
Q1 | – | Sell |
-2,847,235
| Closed | -$341M | – | 8570 |
|
|
2016
Q4 | $330M | Buy |
2,847,235
+1,632,182
| +134% | +$182M | 0.33% | 29 |
|
|
2016
Q3 | $127M | Buy |
1,215,053
+622,075
| +105% | +$67.3M | 0.13% | 110 |
|
|
2016
Q2 | $58.5M | Buy |
592,978
+454,003
| +327% | +$47M | 0.07% | 275 |
|
|
2016
Q1 | $13.9M | Sell |
138,975
-1,026,027
| -88% | -$106M | 0.02% | 975 |
|
|
2015
Q4 | $140M | Buy |
+1,165,002
| New | +$135M | 0.15% | 120 |
|
|
2015
Q3 | – | Sell |
-1,500
| Closed | -$186K | – | 9715 |
|
|
2015
Q2 | $174K | Sell |
1,500
-71,011
| -98% | -$8.12M | ﹤0.01% | 6495 |
|
|
2015
Q1 | $8.36M | Sell |
72,511
-852,122
| -92% | -$102M | 0.01% | 1602 |
|
|
2014
Q4 | $103M | Buy |
924,633
+219,388
| +31% | +$23.1M | 0.1% | 194 |
|
|
2014
Q3 | $66.8M | Sell |
705,245
-188,142
| -21% | -$17M | 0.07% | 306 |
|
|
2014
Q2 | $76.7M | Buy |
893,387
+54,099
| +6% | +$4.11M | 0.09% | 239 |
|
|
2014
Q1 | $58.6M | Sell |
839,288
-66,742
| -7% | -$5.29M | 0.07% | 341 |
|
|
2013
Q4 | $76.5M | Buy |
906,030
+216,012
| +31% | +$17.1M | 0.1% | 209 |
|
|
2013
Q3 | $53.1M | Sell |
690,018
-891,964
| -56% | -$62.5M | 0.08% | 288 |
|
|
2013
Q2 | $92.5M | Buy |
+1,581,982
| New | +$95.2M | 0.16% | 114 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Citadel Advisors's CELG Position: Q4 2019 in Review
Citadel Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,854,309 shares — an estimated $681M sold.
Citadel Advisors first reported a position in CELG in Q2 2013 and held it in 22 quarters. The position peaked at $681M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Citadel Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Citadel Advisors sold 6,854,309 Celgene Corp shares in Q4 2019, an estimated $681M.
- Citadel Advisors first reported a position in Celgene Corp in Q2 2013 and held it in 22 quarters.
- Citadel Advisors's Celgene Corp position peaked at $681M in Q3 2019.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Citadel Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.